Related references
Note: Only part of the references are listed.Toll-Like Receptor 4 Deficiency Decreases Atherosclerosis But Does Not Protect Against Inflammation in Obese Low-Density Lipoprotein Receptor-Deficient Mice
Yilei Ding et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Comparison of Fibrate, Ezetimibe, Low- and High-Dose Statin Therapy for the Dyslipidemia of the Metabolic Syndrome in a Mouse Model
Kosmas I. Paraskevas et al.
ANGIOLOGY (2011)
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
Lutgarda Bozzetto et al.
ATHEROSCLEROSIS (2011)
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
Kei Yunoki et al.
ATHEROSCLEROSIS (2011)
Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice
J. Yoon et al.
DIABETOLOGIA (2011)
Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome
Kazuhiko Kotani et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
Savitha Subramanian et al.
JOURNAL OF LIPID RESEARCH (2011)
Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
Tomonori Muraoka et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man
J. M. Schattenberg et al.
DIGESTIVE DISEASES (2010)
Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis
Lin Jia et al.
JOURNAL OF LIPID RESEARCH (2010)
Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice
Masaya Fukuda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Vascular protective effects of ezetimibe in ApoE-deficient mice
Hironori Nakagami et al.
ATHEROSCLEROSIS (2009)
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki et al.
JOURNAL OF HEPATOLOGY (2009)
Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
Andre J. Tremblay et al.
JOURNAL OF LIPID RESEARCH (2009)
From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation
L. Lionetti et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
Christopher P. Cannon et al.
AMERICAN HEART JOURNAL (2008)
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
Eric D. Labonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice
Savitha Subramanian et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Fatty liver - A novel component of the metabolic syndrome
Anna Kotronen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Shuqin Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adipocyte-derived serum amyloid A3 and hyaluronan play a role monocyte recruitment and adhesion
Chang Yeop Han et al.
DIABETES (2007)
Zetia: Inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia
Harry R. Davis et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2007)
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases
Eugenio Cersosimo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Effect of Ezetimibe on the in vivo kinetics of ApoB-48 and ApoB-100 in men with primary hypercholesterolemia
AJ Tremblay et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
R Shiri-Sverdlov et al.
JOURNAL OF HEPATOLOGY (2006)
Adipose tissue, inflammation, and cardiovascular disease
AH Berg et al.
CIRCULATION RESEARCH (2005)
Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice
KE Lewis et al.
CIRCULATION (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease
JR Sowers et al.
MEDICAL CLINICS OF NORTH AMERICA (2004)
Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes
E Leinonen et al.
ATHEROSCLEROSIS (2003)
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events
PM Ridker et al.
CIRCULATION (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
